| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a59e94c40e64887f93631f6aa1e83121 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-6009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-2026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-3123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-2073 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-2033 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-315 |
| filingDate |
2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae970e9616f5d5adf63b9f29cdb5a3f |
| publicationDate |
2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2014366178-A1 |
| titleOfInvention |
Wearable medication administration device |
| abstract |
A medication administration device is provided. The device has a flexible tube having an administration end, an activation end and a lumen between the ends. An administration assembly is attached to the administration end. An activation assembly is attached to the activation end. A syringe is disposed within the lumen. The syringe contains the medication and has a first end and an opposite second end. A plunger is disposed within the lumen and operatively connected to the first end of the syringe. A rupturable seal is provided to the second end of the syringe, which end is approximate to the administration end. The activation assembly activates the plunger to break the rupturable seal to establish a fluid communication between the second end of the syringe and the administration assembly. Accordingly, transportation of the medication from the syringe to the medication administration assembly through the medication administration end is allowed. |
| priorityDate |
2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |